Search Results
Jul 14, 2026, 07:53 ET Family's Experience with a Mischievous Puppy Inspires New Children's Picture Book
puppy whose playful mischief tests the patience of her new family while highlighting the responsibilities and lasting bonds that come with welcoming a pet into the home.
More news about: Archway Publishing
Jul 14, 2026, 04:50 ET VARON Expands Pet Oxygen Solutions with New Portable Oxygen Bundle and Pet Oxygen Mask
design, this portable oxygen setup allows pet owners to bring oxygen support wherever their pets need it.Expanding VARON's Pet Oxygen Care EcosystemThe launch of the portable pet oxygen bundle and oxygen mask expands VARON's growing range of pet oxygen solutions.From dedicated
More news about: VARON
Jul 14, 2026, 00:01 ET ALZHEIMER'S BLOOD TEST COULD BRING HIGHLY ACCURATE DIAGNOSIS INTO EVERYDAY CLINICAL CARE
for confirmation, as is appropriate, he noted.Today, the standard of care for confirming Alzheimer's disease involves specialized tests such as PET scans (brain imaging) and spinal fluid analysis, tools that are often costly and not widely available outside of memory clinics."This is hopeful
More news about: Alzheimer’s Association
Jul 13, 2026, 19:03 ET ADDF Statement: FDA Approval of Subcutaneous Starting Dose for Leqembi Advances Alzheimer's Care Toward Combination Therapy Future
academia and the biotech industry. The ADDF's leadership and contributions to the field have played a pivotal role in bringing the first Alzheimer's PET scan (Amyvid®) and blood test (PrecivityAD®) to market, as well as fueling the current robust and diverse drug pipeline. Through the generosity of its
More news about: Alzheimer's Drug Discovery Foundation
Jul 13, 2026, 17:36 ET FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
amyloid PET, where 0 CL is anchored as the average amyloid in young people without amyloid plaques, and 100 is anchored as the average amyloid level in moderate AD. The baseline centiloid level in CLARITY AD was approximately 78 CL. Plaque negativity is defined as conversion to amyloid PET negative
More news about: Eisai Inc.
Jul 13, 2026, 17:00 ET Boqii Holding Limited Filed Annual Report on Form 20-F for Fiscal Year 2026
[email protected] Boqii Holding LimitedBoqii Holding Limited (NYSE American: BQ) is a leading pet-focused platform in China. Boqii is the leading online destination for pet products and supplies in China with a broad selection of high-quality products including global leading brands,
More news about: Boqii Holding Limited
Jul 13, 2026, 13:45 ET InventHelp Inventor Develops New Post-Operative Collar for Pets (CNC-1158)
for pets recovering from a surgery or wound," said an inventor, from Charlotte, N.C., "so I invented the E Z BREEZY E- COLLAR. My design allows the pet to easily see, eat, drink, and for felines, to use a litter box. It also prevents them from licking or biting the healing area, and it may inhibit them
More news about: InventHelp
Jul 13, 2026, 11:06 ET The AVMA and Walt Disney World's Top Veterinarian Share Secrets to Better Pet Care
AVMA), there are surprising connections between wildlife medicine and everyday pet care.
More news about: American Veterinary Medical Association
Jul 13, 2026, 10:31 ET Metastatic Castration-resistant Prostate Cancer Market Poised for Strong Growth by 2036, Due to the Launch of Drug Classes Such as Anti-B7-H3 ADC, PROTAC Protein Degrader, NTD AR Inhibitor, Radionuclide Therapy, and Several Others | DelveInsight
indications, and ongoing clinical trials are expected to accelerate the adoption of this therapeutic modality.Advances in PSMA-PET Imaging: The emergence of PSMA-PET imaging has significantly improved the diagnostic landscape of advanced prostate cancer.Launch of Emerging mCRPC Drugs: The
More news about: DelveInsight Business Research, LLP
Jul 13, 2026, 10:12 ET The Alzheimer's Drug Discovery Foundation and The Michael J. Fox Foundation Launch $5 Million Partnership to Target Key Co-Pathologies Driving Alzheimer's and Parkinson's
academia and the biotech industry. The ADDF's leadership and contributions to the field have played a pivotal role in bringing the first Alzheimer's PET scan (Amyvid®) and blood test (PrecivityAD®) to market, as well as fueling the current robust and diverse drug pipeline. Through
More news about: Alzheimer's Drug Discovery Foundation
Jul 13, 2026, 05:30 ET INDIANA UNIVERSITY AND PHARMATROPHIX PRESENT FINDINGS ON PERFORMANCE OF ORAL THERAPEUTIC, LM11A-31, TO REDUCE DECLINE OF BRAIN FUNCTIONAL-NETWORK CONNECTIVITY IN ALZHEIMER'S DISEASE
relevant to cognitive function.The Indiana University research team led by Paul R. Territo, PhD, and Juan Antonio Chong Chie, PhD, processed 18F-FDG-PET scan data from 159 participants in the Phase 2a trial of LM11A-31 with mild to moderate Alzheimer's disease. The trial consisted of three groups (placebo,
More news about: PharmatrophiX
Jul 13, 2026, 04:00 ET Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference® (AAIC®) 2026
blood biomarker assay measuring eMTBR-tau243 was developed as a potential alternative for cerebrospinal fluid (CSF) and Positron Emission Tomography (PET) testing. This analysis evaluated changes in plasma tau biomarkers following etalanetug administration and compared them with changes observed in CSF
More news about: Eisai Inc.
Jul 13, 2026, 00:08 ET New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer's disease
profile in a broad patient population.Efficacy driven by exposure, not route of administration: Amyloid removal measured by amyloid PET, clinical efficacy measured by CDR-SB, and the incidence of ARIA-E were driven by lecanemab exposure rather than the route of administration. The 500
More news about: BioArctic
Jul 13, 2026, 00:02 ET New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer's disease
profile in a broad patient population.Efficacy driven by exposure, not route of administration: Amyloid removal measured by amyloid PET, clinical efficacy measured by CDR-SB, and the incidence of ARIA-E were driven by lecanemab exposure rather than the route of administration. The 500
More news about: BioArctic
Jul 12, 2026, 11:15 ET LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference® (AAIC®) 2026
pharmacokinetic profile in a broad patient population.Efficacy Driven by Exposure, Not Route of Administration: Amyloid removal measured by amyloid PET, clinical efficacy measured by CDR-SB, and the incidence of ARIA-E were driven by lecanemab exposure rather than route of administration. The 500 mg
More news about: Eisai Inc.
Jul 10, 2026, 14:53 ET SIGGRAPH 2026 Experience Hall Invites Attendees to Step Inside the Future of Interaction and Storytelling
"Smileoyed: Embodied Virtual Pet for Behavioral Affective Synchrony with Multisensory and Biofeedback", from teams at National Taipei University of Technology and National Taiwan University, uses a cushion-like device whose virtual pet responds to a user's breathing and facial expressions.
More news about: SIGGRAPH 2026
Jul 10, 2026, 14:45 ET BayCare Marks Milestone in Expanding Access to Care in Manatee County
Primary and specialty care through BayCare Medical GroupOutpatient laboratory servicesAdvanced imaging, including MRI, CT, PET CT, mammography, X-ray, DEXA and ultrasoundThe HealthHub model reflects BayCare's approach to making care more accessible by bringing multiple
More news about: BayCare Health System
Jul 10, 2026, 14:28 ET Mars Impact Fund commits $1M to World Central Kitchen to support earthquake relief efforts in Venezuela
Our international networks of pet hospitals, including BANFIELD™, BLUEPEARL™, VCA™ and ANICURA™ span preventive, general, specialty, and emergency veterinary care, and our global veterinary diagnostics business ANTECH® offers breakthrough capabilities in pet diagnostics. The Mars Five Principles
More news about: Mars, Incorporated
Jul 10, 2026, 14:10 ET Mars Impact Fund commits $1M to World Central Kitchen to support earthquake relief efforts in Venezuela
Our international networks of pet hospitals, including BANFIELD™, BLUEPEARL™, VCA™ and ANICURA™ span preventive, general, specialty, and emergency veterinary care, and our global veterinary diagnostics business ANTECH® offers breakthrough capabilities in pet diagnostics. The Mars Five Principles
More news about: Mars, Incorporated
Jul 10, 2026, 10:00 ET OlloBot Reveals OlloNi SS1's New Identity Design and Announces Ollo-Family Blind Box Launch at Houston Pop-Up This July
intelligence and developing proactive, family-centric AI companion cyber-pet robots. The brand focuses on creating emotionally intelligent embodied AI that brings warmth, presence, and genuine connection to modern homes. Pioneering the Cyber Pet category, OlloBot integrates AI and robotics into real domestic
More news about: OlloBot
Jul 10, 2026, 08:51 ET Legendary Hip-Hop Icon Tone Loc Returns With New Animated Social Media Project
enjoyed a successful career in film and television. In addition to "C-Bear and Jamal," his extensive credits include appearances in "Heat," "Ace Ventura: Pet Detective," "Blank Check," and "Posse," along with voice work in "FernGully: The Last Rainforest," and "Bebe's Kids."Tone Loc's foray into the
More news about: Tone Loc
Jul 10, 2026, 07:06 ET Outward Hound anuncia a H.I.G. Capital como nuevo accionista mayoritario
golosinas de alta calidad para perros y gatos. Las marcas de la compañía incluyen Outward Hound®, Best Friends by Sheri®, Catstages™, Wholesome Pride Pet Treats®, Nina Ottosson®, Planet Dog® y Pupstages®. La sede central de Outward Hound® se encuentra en Centennial, Colorado, a las afueras de Denver. Para
More news about: Outward Hound
Jul 09, 2026, 19:25 ET Outward Hound gibt H.I.G. Capital als neuen Mehrheitseigner bekannt, um die nächste Wachstumsphase voranzutreiben
Schlafplätzen und Leckerlis für Hunde und Katzen. Zu den Marken des Unternehmens zählen Outward Hound®, Best Friends by Sheri®, Catstages™, Wholesome Pride Pet Treats®, Nina Ottosson®, Planet Dog® und Pupstages®. Outward Hound® hat seinen Hauptsitz außerhalb von Denver in Centennial, Colorado. Weitere Informationen
More news about: Outward Hound
Jul 09, 2026, 19:21 ET Outward Hound annonce l'arrivée de H.I.G. Capital en tant que nouvel actionnaire majoritaire pour soutenir sa prochaine phase de croissance
de haute qualité pour chiens et chats. Parmi les marques de l'entreprise figurent Outward Hound®, Best Friends by Sheri®, Catstages™, Wholesome Pride Pet Treats®, Nina Ottosson®, Planet Dog® et Pupstages®. Outward Hound® a son siège social à Centennial, dans le Colorado, près de Denver. Pour en savoir
More news about: Outward Hound
Jul 09, 2026, 18:45 ET Outward Hound Announces H.I.G. Capital as New Majority Owner to Support Next Chapter of Growth
behind our brands, accelerate product innovation, and pursue growth opportunities. We remain focused on building on what makes Outward Hound valuable to pet parents and retail partners: distinctive brands, strong product development, and trusted customer relationships."Vivek Jain, Managing Director
More news about: Outward Hound